Invention Grant
US07807165B2 Antibodies directed against amyloid-beta peptide and methods using same
有权
针对淀粉样蛋白-β肽的抗体及其使用方法
- Patent Title: Antibodies directed against amyloid-beta peptide and methods using same
- Patent Title (中): 针对淀粉样蛋白-β肽的抗体及其使用方法
-
Application No.: US11195207Application Date: 2005-08-01
-
Publication No.: US07807165B2Publication Date: 2010-10-05
- Inventor: Arnon Rosenthal , Jaume Pons , Wei-Hsien Ho , Jan Markus Grimm
- Applicant: Arnon Rosenthal , Jaume Pons , Wei-Hsien Ho , Jan Markus Grimm
- Applicant Address: US CA South San Francisco
- Assignee: Rinat Neuroscience Corp.
- Current Assignee: Rinat Neuroscience Corp.
- Current Assignee Address: US CA South San Francisco
- Agent Gregg C. Benson; Garth Butterfield; Raquel M. Alvarez
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00
Abstract:
Monoclonal antibody 9TL and antibodies derived from 9TL directed against amyloid-beta peptide and methods of using same for diagnosing and treatment of Alzheimer's disease and Aβ peptide associated diseases are described. Methods of using antibodies directed against amyloid-beta peptide having impaired effector function for treatment of Alzheimer's disease and Aβ peptide associated diseases are also described.
Public/Granted literature
- US20060057702A1 Antibodies directed against amyloid-beta peptide and methods using same Public/Granted day:2006-03-16
Information query
